How Brain May Deliberately Form Amyloids to Turn Experiences Into Memories

Why It Matters

Demonstrating regulated, functional amyloid formation reshapes our understanding of memory biology and opens novel therapeutic pathways for neurodegeneration and cognitive disease.

Key Takeaways

• Funes chaperone triggers Orb2 amyloid formation for lasting memory
• Overexpressing Funes enhances 24‑hour odor‑reward memory in flies
• Disabling Funes‑Orb2 interaction abolishes long‑term memory
• Functional amyloids may be universal across vertebrate brains
• Links between J‑domain chaperones and schizophrenia emerge

Pulse Analysis

The discovery that a molecular chaperone can orchestrate amyloid assembly for memory storage marks a paradigm shift in neuroscience. For decades, amyloids have been synonymous with neurodegenerative disease, yet the Stowers Institute team shows that in Drosophila, the J‑domain protein Funes directs the prion‑like Orb2 to form translationally active amyloid fibrils at synapses. This controlled aggregation stabilizes synaptic protein networks, providing a durable substrate for long‑term memory without the toxicity traditionally associated with amyloid plaques.

In the experimental paradigm, flies were trained to associate an unpleasant odor with a sugar reward. Elevating Funes levels in the mushroom bodies—a key memory center—produced robust recall after 24 hours, whereas engineered Funes variants that could bind Orb2 but not induce amyloid formation failed to support memory. These results pinpoint Funes as a critical regulator that times amyloid formation precisely after learning events, suggesting that similar chaperone‑driven mechanisms could exist in more complex brains, including mammals, where the Orb2 ortholog CPEB performs analogous functions.

Beyond basic science, the study bridges memory biology with disease relevance. The same family of type III J‑domain chaperones implicated in memory modulation has surfaced in genome‑wide association studies of schizophrenia, hinting at a broader role in psychiatric conditions. If functional amyloid pathways can be harnessed or modulated, they may offer strategies to counteract toxic amyloid accumulation in Alzheimer’s, Parkinson’s, and related disorders, or to enhance cognitive resilience. Future work will focus on identifying mammalian counterparts of Funes and translating these insights into therapeutic interventions.